Amino Acid Metabolism Practice Questions

Q: A newborn presents with vomiting, lethargy, and failure to thrive. Laboratory tests reveal metabolic acidosis and elevated levels of propionic acid. Which enzyme deficiency is most likely?

Propionyl-CoA carboxylase. ***Propionyl-CoA carboxylase*** - **Propionyl-CoA carboxylase deficiency** (propionic acidemia) leads to the accumulation of **propionic acid** due to the inability to convert **propionyl-CoA** to **methylmalonyl-CoA**. - This accumulation results in **metabolic acidosis**, vomiting, lethargy, and **failure to thrive** in newborns. - This is a **biotin-dependent enzyme**, so some cases may respond to biotin supplementation. *Phenylalanine hydroxylase* - Deficiency of **phenylalanine hydroxylase** causes **phenylketonuria (PKU)**, leading to elevated phenylalanine levels. - PKU typically presents with intellectual disability, seizures, and a musty odor, not primarily with elevated propionic acid. *Branched-chain α-ketoacid dehydrogenase* - Deficiency in **branched-chain α-ketoacid dehydrogenase** causes **maple syrup urine disease (MSUD)**, characterized by the accumulation of branched-chain amino acids (leucine, isoleucine, valine). - MSUD presents with a characteristic maple syrup odor in urine, feeding difficulties, and neurological symptoms, not elevated propionic acid. *Ornithine transcarbamylase* - **Ornithine transcarbamylase (OTC) deficiency** is an **X-linked urea cycle disorder** resulting in hyperammonemia. - Symptoms include lethargy, coma, and respiratory alkalosis due to ammonia toxicity, not elevated propionic acid or primary metabolic acidosis.

Q: A child presents with developmental delay and a musty odor. Which enzyme deficiency is most likely?

Phenylalanine hydroxylase. ***Phenylalanine hydroxylase*** - Deficiency of **phenylalanine hydroxylase** leads to the accumulation of **phenylalanine** and its metabolites, causing **phenylketonuria (PKU)**. - The elevated phenylalanine metabolites, such as **phenylacetate**, are responsible for the characteristic **"musty" or "mousy" odor** in affected children, along with **developmental delay** if untreated. *Tyrosinase* - Deficiency of **tyrosinase** is associated with **albinism**, a condition characterized by a lack of melanin production leading to **hypopigmentation of the skin, hair, and eyes**. - It does not typically present with a musty odor or primarily with global developmental delay in the absence of other symptoms. *Homogentisate oxidase* - Deficiency of **homogentisate oxidase** causes **alkaptonuria**, a genetic disorder characterized by the accumulation of **homogentisic acid**. - This leads to **dark urine upon standing**, **ochronosis** (dark pigmentation of cartilage and connective tissues), and severe **osteoarthritis** in adulthood, not a musty odor or early developmental delay. *Dihydropteridine reductase* - Deficiency of **dihydropteridine reductase** leads to a **tetrahydrobiopterin (BH4) deficiency**, which is a co-factor for phenylalanine hydroxylase, as well as tyrosine hydroxylase and tryptophan hydroxylase. - This can cause a **"malignant" form of PKU** with **severe neurological symptoms** due to impaired neurotransmitter synthesis, but a distinct musty odor is more specifically associated with direct phenylalanine hydroxylase deficiency.

Q: What dietary modification is recommended to manage hyperammonemia in patients with ornithine transcarbamylase deficiency?

Low-protein diet. ***Correct: Low-protein diet*** - **Ornithine transcarbamylase (OTC) deficiency** impairs the urea cycle's ability to convert **ammonia from protein catabolism** into urea. - A **low-protein diet** reduces the substrate for ammonia production, thereby helping to manage hyperammonemia. - This is the **primary dietary modification** for managing OTC deficiency. *Incorrect: High-carbohydrate diet* - While a **high-carbohydrate diet** might be used to provide calories and spare protein, it is not the primary dietary modification for *managing ammonia levels* directly. - Its role is secondary to protein restriction, focusing on adequate energy intake. *Incorrect: Low-carbohydrate diet* - A **low-carbohydrate diet** would typically lead to increased reliance on **fat and protein metabolism for energy**, potentially exacerbating hyperammonemia due to increased protein breakdown. - It is generally not recommended for managing OTC deficiency. *Incorrect: High-protein diet* - A **high-protein diet** would significantly *increase the nitrogen load* and, consequently, **ammonia production**, worsening hyperammonemia in patients with OTC deficiency. - This diet would be detrimental and is contraindicated in such patients.

Q: Which enzyme deficiency is directly responsible for the accumulation of phenylalanine in the blood of individuals with phenylketonuria?

Phenylalanine hydroxylase. ***Correct: Phenylalanine hydroxylase*** - This enzyme is crucial for converting **phenylalanine** into **tyrosine** - Its deficiency leads to the buildup of phenylalanine in the blood, which is characteristic of **phenylketonuria (PKU)** - PKU is an **autosomal recessive disorder** and one of the most common inborn errors of metabolism - Without treatment, elevated phenylalanine causes **intellectual disability, seizures, and behavioral problems** *Incorrect: Hexokinase* - This enzyme is involved in the **first step of glycolysis**, phosphorylating glucose to glucose-6-phosphate - Deficiency of hexokinase does not directly cause an accumulation of phenylalanine - It is unrelated to amino acid metabolism *Incorrect: Glucokinase* - Glucokinase is an enzyme that facilitates the **phosphorylation of glucose to glucose-6-phosphate** in the liver and pancreatic beta cells - Its dysfunction is associated with certain types of **maturity-onset diabetes of the young (MODY)**, but not with phenylalanine metabolism disorders - It serves as the glucose sensor in pancreatic beta cells *Incorrect: Pyruvate kinase* - This enzyme catalyzes the **final step of glycolysis**, converting phosphoenolpyruvate to pyruvate - Deficiencies in pyruvate kinase can lead to **hemolytic anemia** but do not impact phenylalanine levels - It is unrelated to amino acid metabolism

Q: Which of the following is a key regulatory enzyme in the urea cycle?

Carbamoyl phosphate synthetase I. ***Carbamoyl phosphate synthetase I*** - This enzyme catalyzes the **first committed step** of the urea cycle, forming **carbamoyl phosphate** from ammonia, bicarbonate, and ATP. - Its activity is tightly regulated, primarily by **N-acetylglutamate**, reflecting changes in protein catabolism and ammonia levels. *Ornithine transcarbamylase* - This enzyme catalyzes the **second step** of the urea cycle, combining **carbamoyl phosphate** with **ornithine** to form citrulline. - While essential for the cycle, it is not considered the primary regulatory point, as its substrate, carbamoyl phosphate, is regulated by CPS I. *Argininosuccinate synthetase* - This enzyme catalyzes the **third step** of the urea cycle, converting **citrulline** and **aspartate** into argininosuccinate. - Its activity is dependent on the availability of citrulline and aspartate, but it does not exert the primary regulatory control over the overall cycle flux. *Arginase* - This enzyme catalyzes the **final step** of the urea cycle, hydrolyzing **arginine** to form urea and regenerating ornithine. - While critical for producing urea and recycling ornithine, its regulation is secondary to the initial rate-limiting step controlled by CPS I.

Q: What is the consequence of a defect in the enzyme branched-chain alpha-keto acid dehydrogenase?

Accumulation of branched-chain amino acids. ***Accumulation of branched-chain amino acids*** - **Branched-chain alpha-keto acid dehydrogenase (BCKDH)** is responsible for the oxidative decarboxylation of alpha-keto acids, which are derived from branched-chain amino acids (BCAAs) like **leucine, isoleucine, and valine**. - A defect in this enzyme leads to the **buildup of BCAAs** and their corresponding alpha-keto acids in the blood and urine, a hallmark of **Maple Syrup Urine Disease**. *Reduced synthesis of fatty acids* - While BCAAs can be used for energy production and contribute to lipid metabolism, a direct and primary consequence of BCKDH defect is not a reduction in fatty acid synthesis. - The main issue lies in the **catabolism of BCAAs**, not necessarily downstream fatty acid production. *Increased glucose synthesis* - The elevated levels of BCAAs can actually inhibit several enzymes involved in **gluconeogenesis**. - Therefore, a defect in BCKDH would more likely lead to impaired, rather than increased, glucose synthesis due to the toxic accumulation of metabolites. *Decreased cholesterol levels* - The catabolism of BCAAs, particularly **leucine**, produces metabolites like **acetyl-CoA** which are precursors for cholesterol synthesis. - While a defect in BCKDH would impair this pathway, the primary and most significant consequence is not decreased cholesterol, but rather the toxic effects of accumulated BCAAs and their alpha-keto acids.

Q: What is the most common inborn error of metabolism that results in phenylketonuria (PKU)?

Phenylalanine hydroxylase deficiency. ***Phenylalanine hydroxylase deficiency*** - This enzyme is crucial for converting **phenylalanine** to **tyrosine**. Its deficiency leads to the accumulation of phenylalanine, causing phenylketonuria (PKU). - More than 95% of PKU cases are attributed to **mutations** in the gene encoding phenylalanine hydroxylase. *Homogentisate oxidase deficiency* - Deficiency of this enzyme causes **alkaptonuria**, a rare genetic disorder characterized by the accumulation of homogentisic acid. - It is distinct from PKU and does not involve the metabolism of phenylalanine to tyrosine. *Branched-chain α-ketoacid dehydrogenase deficiency* - This enzyme deficiency is associated with **maple syrup urine disease (MSUD)**, a disorder of branched-chain amino acid metabolism. - MSUD affects the metabolism of **leucine, isoleucine, and valine**, not phenylalanine. *Ornithine transcarbamylase deficiency* - This deficiency is the most common **urea cycle disorder**, leading to hyperammonemia. - It primarily affects the body's ability to remove **ammonia** and is unrelated to phenylalanine metabolism.

Q: A patient has elevated levels of both homocysteine and methionine. Which enzyme deficiency could be the cause?

Cystathionine β-synthase. ***Cystathionine β-synthase*** - A deficiency in **cystathionine β-synthase (CBS)** leads to the accumulation of both **homocysteine** and **methionine** because homocysteine cannot be converted into cystathionine, causing it to build up. - The elevated homocysteine also inhibits methionine metabolism, leading to methionine accumulation as well. - This condition is known as **classical homocystinuria**, characterized by elevated levels of both these amino acids in blood and urine. *Methionine synthase* - **Methionine synthase** (also known as homocysteine methyltransferase) catalyzes the conversion of **homocysteine to methionine**, using methylcobalamin (vitamin B12) and methyltetrahydrofolate. - A deficiency in this enzyme would lead to **elevated homocysteine** but **decreased methionine**, as methionine cannot be regenerated from homocysteine. *Cystathionine γ-lyase* - **Cystathionine γ-lyase (cystathionase)** is the enzyme downstream of CBS that converts **cystathionine to cysteine** in the transsulfuration pathway. - A deficiency causes **cystathioninuria** with elevated cystathionine but typically **normal or mildly elevated homocysteine and methionine**. - This does not match the clinical picture of elevated both homocysteine and methionine. *S-adenosylmethionine synthetase* - **S-adenosylmethionine (SAM) synthetase** converts **methionine into SAM**, which is a crucial methyl donor in methylation reactions. - A deficiency would cause **elevated methionine** but **normal or decreased homocysteine**, as methionine would not be efficiently converted to SAM and subsequently to homocysteine. - This deficiency is rare and presents with hepatic dysfunction and neurological issues.

Q: Which process is primarily responsible for converting ammonia to a less toxic substance in the liver?

The Urea Cycle. ***The Urea Cycle*** - The **urea cycle** is the primary metabolic pathway in the liver for converting highly toxic **ammonia** into less toxic **urea**, which can then be safely excreted by the kidneys. - This cycle is crucial for detoxification of ammonia, a byproduct of amino acid metabolism. - Key enzymes include **carbamoyl phosphate synthetase I**, ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, and arginase. *Glycolysis* - Glycolysis is a metabolic pathway that breaks down glucose into pyruvate, producing energy (ATP). - It does not play any direct role in ammonia detoxification. *The Citric Acid Cycle* - The Citric Acid Cycle (Krebs cycle) is a central metabolic pathway for generating ATP through the oxidation of acetyl-CoA. - While it interfaces with amino acid metabolism, it is not directly responsible for converting ammonia to urea. *Beta-oxidation* - Beta-oxidation is the process by which fatty acids are broken down into acetyl-CoA for energy production. - This process is involved in lipid metabolism and has no direct function in ammonia detoxification.

Q: A patient with hyperammonemia is found to have elevated levels of citrulline. Which enzyme deficiency is most likely?

Argininosuccinate synthetase deficiency. ***Argininosuccinate synthetase deficiency*** - A deficiency in **argininosuccinate synthetase** (ASS) prevents the conversion of **citrulline** and **aspartate** to argininosuccinate, leading to the accumulation of **citrulline**. - The accumulated citrulline diffuses out of the hepatocytes and into the bloodstream, resulting in **elevated plasma citrulline** levels, which is a hallmark of this disorder, also known as **Citrullinemia Type I**. *CPS I deficiency* - **Carbamoyl phosphate synthetase I (CPS I)** is the first committed step of the urea cycle; a deficiency results in the inability to synthesize **carbamoyl phosphate**. - This leads to severe **hyperammonemia** but very **low levels of citrulline** and arginine, as the cycle cannot progress beyond the initial stages. *OTC deficiency* - **Ornithine transcarbamylase (OTC)** deficiency prevents the conversion of **carbamoyl phosphate** and **ornithine** to citrulline. - This common X-linked disorder causes **severe hyperammonemia** with **low blood citrulline** levels, contrasting with the elevated citrulline seen in the patient. *Arginase deficiency* - **Arginase** catalyzes the final step of the urea cycle, converting **arginine** to ornithine and urea. - A deficiency leads to an accumulation of **arginine** and **hyperargininemia**, with **normal or only modestly elevated levels of citrulline**, along with hyperammonemia, which is distinct from the primary elevation of citrulline.

Question 1

A newborn presents with vomiting, lethargy, and failure to thrive. Laboratory tests reveal metabolic acidosis and elevated levels of propionic acid. Which enzyme deficiency is most likely?

Accepted Answer

Propionyl-CoA carboxylase

Answer

Phenylalanine hydroxylase

Answer

Branched-chain α-ketoacid dehydrogenase

Answer

Ornithine transcarbamylase

Question 2

A child presents with developmental delay and a musty odor. Which enzyme deficiency is most likely?

Accepted Answer

Phenylalanine hydroxylase

Answer

Tyrosinase

Answer

Homogentisate oxidase

Answer

Dihydropteridine reductase

Question 3

What dietary modification is recommended to manage hyperammonemia in patients with ornithine transcarbamylase deficiency?

Accepted Answer

Low-protein diet

Answer

Low-carbohydrate diet

Answer

High-carbohydrate diet

Answer

High-protein diet

Question 4

Which enzyme deficiency is directly responsible for the accumulation of phenylalanine in the blood of individuals with phenylketonuria?

Accepted Answer

Phenylalanine hydroxylase

Answer

Hexokinase

Answer

Glucokinase

Answer

Pyruvate kinase

Question 5

Which of the following is a key regulatory enzyme in the urea cycle?

Accepted Answer

Carbamoyl phosphate synthetase I

Answer

Ornithine transcarbamylase

Answer

Argininosuccinate synthetase

Answer

Arginase

Question 6

What is the consequence of a defect in the enzyme branched-chain alpha-keto acid dehydrogenase?

Accepted Answer

Accumulation of branched-chain amino acids

Answer

Reduced synthesis of fatty acids

Answer

Increased glucose synthesis

Answer

Decreased cholesterol levels

Question 7

What is the most common inborn error of metabolism that results in phenylketonuria (PKU)?

Accepted Answer

Phenylalanine hydroxylase deficiency

Answer

Homogentisate oxidase deficiency

Answer

Branched-chain α-ketoacid dehydrogenase deficiency

Answer

Ornithine transcarbamylase deficiency

Question 8

A patient has elevated levels of both homocysteine and methionine. Which enzyme deficiency could be the cause?

Accepted Answer

Cystathionine β-synthase

Answer

Methionine synthase

Answer

Cystathionine γ-lyase

Answer

S-adenosylmethionine synthetase

Question 9

Which process is primarily responsible for converting ammonia to a less toxic substance in the liver?

Accepted Answer

The Urea Cycle

Answer

Glycolysis

Answer

The Citric Acid Cycle

Answer

Beta-oxidation

Question 10

A patient with hyperammonemia is found to have elevated levels of citrulline. Which enzyme deficiency is most likely?

Accepted Answer

Argininosuccinate synthetase deficiency

Answer

CPS I deficiency

Answer

OTC deficiency

Answer

Arginase deficiency

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?